Search  in | Advanced
   Print  
Support for a U.S. Hemovigilance/Biovigilance Program - 5/9/06
TRALI - BPAC - 7-22-04
West Nile Virus - BPAC - 12-11-03
SARS - Final Guidance - 12-5-03
Reducing Mis-transfusion - AHRQ Patient Safety Summit - 11-7-03
Safety Reporting Requirements - Proposed Rule - 10-13-03
Circular of Information - Guidance - 1-8-03
SARS - BPAC - 6-19-03
West Nile Virus: Frozen Products Withdrawal - BPAC - 12-12-02
Bacterial Contamination of Platelet Components - BPAC - 12-12-02
Transfusion-Related Acute Lung Injury (TRALI) - BPAC - 6-15-01
Bacterial Contamination Reduction - BPAC - 3-15-01
Last modified on 5/11/2006 6:50:08 AM
What's New!
AABB Weekly Report - March 5, 2010
Details
National Hemovigilance Program Launches to Track Adverse Events Associated with Blood Transfusion
Details
AABB Statement on XMRV Task Force
Details
Updated Circular of Information for Cellular Therapy Products
Details
Association Bulletin #10-01 - Association Bulletin Listings
Details
Current U.S. Blood Supply is Adequate to Handle Demands Resulting from Earthquake in Haiti
Details
Emerging Infectious Disease Agents
Details
Study Highlights Implications Of Influenza Pandemics On Blood Supplies
Details
Cellular Therapies Subsections
Details
Association Bulletin #09-08 - ISBT 128 Conditional Accreditation Status
Details
AABB Launches Facebook Fan Page
Details